Moxifloxacin Decarboxy Analog
|
|
Moxifloxacin Decarboxy Analog 속성
- 끓는 점
- 561.3±50.0 °C(Predicted)
- 밀도
- 1.300±0.06 g/cm3(Predicted)
- 용해도
- 클로로포름(약간 용해됨), DMSO(약간 용해됨), 메탄올(약간 용해됨)
- 산도 계수 (pKa)
- 10.63±0.20(Predicted)
- 물리적 상태
- 고체
- 물리적 상태
- 단단한 모양
- 색상
- 황백색에서 노란색까지
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
그림문자(GHS): | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Warning | ||||||||||||||
유해·위험 문구: |
|
||||||||||||||
예방조치문구: |
|
Moxifloxacin Decarboxy Analog C화학적 특성, 용도, 생산
용도
A degradation product of Moxifloxacin (M745000). Moxifloxacin impurity.Moxifloxacin Decarboxy Analog 준비 용품 및 원자재
원자재
준비 용품
Moxifloxacin Decarboxy Analog 공급 업체
글로벌( 63)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Standardpharm Co. Ltd. | 86-714-3992388 |
overseasales1@yongstandards.com | United States | 14336 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 19892 | 58 |
sgtlifesciences pvt ltd | +8617013299288 |
dj@sgtlifesciences.com | China | 12382 | 58 |
Guangzhou Tosun Pharmaceutical Limited | +8618922120635 |
sales@toref-standards.com | China | 1000 | 58 |
LEAPCHEM CO., LTD. | +86-852-30606658 |
market18@leapchem.com | China | 43348 | 58 |
Perida Pharmaceutical Co., Ltd. | 010-87568995 13439954790 |
2539095144@qq.com | China | 181 | 58 |
Shenzhen Botel Biotechnology Co. Ltd. | 0755-22202135 13316968096 |
1979313431@qq.com | China | 7642 | 58 |
S.Z. PhyStandard Bio-Tech. Co., Ltd. | 0755-4000505016 13380397412 |
3001272453@qq.com | China | 4978 | 50 |
ChemStrong Scientific Co.,Ltd | 0755-66853366 13670046396 |
sales@chem-strong.com | China | 17982 | 56 |
Nanjing XiZe Biotechnology CO., Ltd. | 025-58362220 15250997978 |
1511893459@qq.com | China | 7715 | 55 |
Moxifloxacin Decarboxy Analog 관련 검색:
Moxifloxacin Impurity 30
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid ethyl ester
3-Quinolinecarboxylic acid, 7-aMino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo-
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-7-8-difluoro-6-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Ethyl Ester
Moxifloxacin Ethyl Ester
ethyl 1-cyclopropyl-8-ethoxy-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate
1-cyclopropyl-8-ethoxy-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-8-ethoxy-6-fluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)-
1-Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxoq
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid
Methyl 1-cyclopropyl-6-fluoro-7-(hexahydro-1H-pyrrolo [3, 4-b]pyridin-6(2H)-yl)-8-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate
N-Methyl Moxifloxacin
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
Moxifloxacin